Navigation Links
International Experts to Review State-of-the-Art Thinking on Signal Detection and Data Mining
Date:10/1/2009

The 2nd DIA Conference on Signal Detection and Data Mining will be held from November 16-18, 2009 in New York, NY. This three-day conference will explore address all aspects of signal detection and data mining, including methodologies, clinical interpretation, and international harmonization initiatives.

Horsham, PA (PRWEB) October 1, 2009 -- The 2nd DIA Conference on Signal Detection and Data Mining will be held from November 16-18, 2009 in New York, NY. This three-day conference will explore address all aspects of signal detection and data mining, including methodologies, clinical interpretation, and international harmonization initiatives.

Experts will discuss:

 
  • Future for analysis of spontaneous reports and other healthcare data with potential applicability to pharmacovigilance
  • Signal detection successes resulting from data mining spontaneous reports, with a discussion of the pitfalls, evaluation and validation of the methods and real-world implementation
  • Update on the networks of pharmacoepidemiology and the use of longitudinal/observational databases for signal detection purposes
  • Update on CIOMS VIII working group on signal detection and management
  • FDA Sentinel Initiative and the Observational Medical Outcomes Partnership (OMOP)

"The use of data mining methods to screen collections of Individual Case Safety Reports for important reporting patterns has gone from proof-of-concept to widespread use," says Program Committee Member Andrew Bate, PhD, Director, Quantitative Epidemiology, Pfizer Inc. "Currently, there is a growing interest in screening other sources of real-world medical information for emerging safety issues and developing computational methods which do not rely on disproportionality analysis. This conference will bring together an international group of experts to review current state-of-the-art thinking on the future developments in data mining and signal detection and a vision of how public health and patient safety issues will be detected faster and more effectively in the future."

Click here to register.

About the Drug Information Association (DIA)
DIA serves more than 30,000 professionals involved in the biopharmaceutical industry and regulatory affairs worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.

Contact: Joe Krasowski
DIA
+1-215-293-5812

# # #

Read the full story at http://www.prweb.com/releases/DIA_conference/signal_detection/prweb2978214.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Profiles International Finds High Employee Utilization is One Key to Maximizing Productivity
2. Temps Inc. Acquires Medical Concepts Staffing Business From Analysts International Corporation
3. Director of UT Southwestern center honored with first international neurology medal
4. Hong Kong International Media Conference 2010
5. Data Released at an International Stem Cell Meeting Highlights Effectiveness of New Patient Education System Developed to Support Federal and State Guidelines on Cord Blood Education
6. McLaren Health Care Forming Partnership With ProTom International to Build First Proton Beam Therapy Center In Michigan
7. Natural Alternatives International, Inc. Announces Fiscal 2009 Q4 and Full Year Results
8. Yanda International Health City - World Class Healthcare in China
9. Osseon Signs International Distribution Agreement With MBA Incorporado
10. Cohera Medical Receives ISO 13485 Certification: Company Meets International Standards for Design, Development and Manufacturing of Medical Devices
11. CEO and Founder of Project Lifesaver International, Gene Saunders, Selected to Receive Two Awards From Local Community
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
International Experts to Review State-of-the-Art Thinking on Signal Detection and Data Mining 
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... 27, 2016 , ... In response to meager public awareness, ... of the plight of aphasia. In collaboration with the American Aphasia Association, a ... The link between stroke and aphasia is relatively unknown, but through collaboration with ...
(Date:5/27/2016)... , ... May 27, 2016 , ... Aimed at nurses ... interest stories, which come courtesy of leaders in the nursing and health care industry. ... leading advocates and associations—namely Abilene Christian University. , As the nursing industry is ...
(Date:5/26/2016)... ... ... Despite last week’s media reports hinting at a June rate hike after the Federal ... an interest rate increase, according to Rajeev Dhawan of the Economic Forecasting Center at ... Committee (FOMC) dot charts are of interest to the press for their noise potential,” ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, ... defective respirators, according to court documents and SEC filings. A jury has ... Tyler v. American Optical Corporation, Case No. BC588866, Los Angeles County, California. The ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... May 27, 2016 Amarantus BioScience Holdings, ... developing products for Regenerative Medicine, Neurology and Orphan Diseases, today announced ... presenting at two upcoming investor conferences: SeeThru Equity ... Avenue, New York City , NY ... Marcum MicroCap Conference   Where: Grand Hyatt Hotel, ...
(Date:5/26/2016)... , May 26, 2016   ... software and analytics, network solutions and technology-enabled ... announced it entered into a strategic channel ... of outpatient software solutions and revenue cycle ... specialty hospitals and rehabilitation clinics to optimize ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May ... QGEN ; Frankfurt Prime Standard: QIA) today announced that ... with Therawis Diagnostics GmbH to develop and commercialize predictive assays ... market PITX2 as a marker to predict effectiveness of anthracycline ... "We are pleased to partner with Therawis, which ...
Breaking Medicine Technology: